Literature DB >> 6328966

Effects of compound 48/80 on hepatic glycogen and glucose-6-phosphatase early in the diurnal cycle of the rat.

R V Dimlich, R R Cardell.   

Abstract

The amount and distribution of glycogen as well as the activity of glucose-6-phosphatase (G-6-Pase) in the livers of rats were analyzed by biochemical and/or histochemical techniques. During the first 5 hr of the light cycle, livers of rats were sampled prior to and 30 min following an injection of compound 48/80 or Ringer's solution. Glycogen decreased significantly in response to sampling; however, treatment with compound 48/80 provoked an additional significant decrease in hepatic glycogen. These differences occurred irrespective of the time during the 5 hr that this was studied. The livers of the majority of the rats treated with compound 48/80 displayed a periportal distribution of glycogen, while those treated with Ringer's showed a more uniform pattern. Hepatic G-6-Pase activity was unchanged in either the Ringer's or compound 48/80 treated rats. These results indicated that (1) the significant glycogenolytic response occurs independently of the amount of glycogen present, (2) G-6-Pase activity is not affected within 30 min following the stimulation of glycogenolysis, (3) variation in glycogen patterns during depletion depends on the nature of the stimulus and/or degree of response, and (4) the amount of glycogen available for release is limited.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328966     DOI: 10.1002/aja.1001690406

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


  1 in total

1.  Compound 48/80, a mast cell degranulator, causes oxidative damage by enhancing vitamin C synthesis via reduced glutathione depletion and lipid peroxidation through neutrophil infiltration in rat livers.

Authors:  Yosihiji Ohta; Koji Yashiro; Koji Ohashi; Yosuke Horikoshi; Chiaki Kusumoto; Tatsuya Matsura
Journal:  J Clin Biochem Nutr       Date:  2017-04-20       Impact factor: 3.114

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.